SCHEMBL7940249

SCHEMBL7940249

COc1cccc(-c2ccc3cc(OC)ccc3c2Oc2ccc(N)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
CYP19A1 P11511 1/20 0.43
CYP3A4 P08684 2/20 0.42
GSTP1 P09211 1/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP4B1 P13584 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP3A5 P20815 1/20 0.42
CYP2A7 P20853 1/20 0.42
CYP3A7 P24462 1/20 0.42
CYP2F1 P24903 1/20 0.42
CYP2C18 P33260 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP2J2 P51589 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7928856 0.91 SMN1; SMN2 (0.51) SMN1; SMN2CYP3A4CYP1A1CYP1A2CYP2E1
SCHEMBL7937708 0.90 SMN1; SMN2 (0.45) SMN1; SMN2CYP19A1CYP3A4CYP1A1CYP1A2
SCHEMBL7934940 0.88 SMN1; SMN2 (0.45) SMN1; SMN2CYP3A4GSTP1CYP1A2CYP2D6
SCHEMBL6050136 0.87 ESR1 (0.50) CYP3A4GSTP1CYP1A1CYP1A2CYP2E1
SCHEMBL7937022 0.85 MAPT (0.44) SMN1; SMN2CYP19A1GSTP1ALDH1A1MEN1
SCHEMBL6050146 0.84 GSTP1 (0.43) SMN1; SMN2CYP3A4GSTP1CYP1A1CYP1A2
SCHEMBL7935076 0.82 ESR1 (0.40) SMN1; SMN2CYP19A1CYP3A4GSTP1CYP1A1
SCHEMBL7937985 0.82 DHFR (0.41) SMN1; SMN2CYP19A1CYP3A4GSTP1CYP1A1
SCHEMBL7928761 0.82 DHFR (0.39) SMN1; SMN2CYP19A1CYP3A4GSTP1CYP1A1
SCHEMBL7928854 0.82 MAOB (0.47) SMN1; SMN2GSTP1ADORA2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835868-B1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 2001-08-29 EP disclosed
US-5929090-A NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS ELI LILLY AND COMPANY (US) 1999-07-27 US disclosed
EP-0835868-A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed